Dissertation > Excellent graduate degree dissertation topics show
The Experimental Study of 125I Labelled Anti-CD28 Monoclonal Antibody 2F5
Author: SuJuan
Tutor: SuChengHai
School: Suzhou University
Course: Medical Imaging and Nuclear Medicine
Keywords: Iodogen method (125)~Ⅰ-2F5 Monoclonal antibody radioimmunoimaging
CLC: R392
Type: Master's thesis
Year: 2011
Downloads: 21
Quote: 0
Read: Download Dissertation
Abstract
|
Objective: To study the (125)~Ⅰlabeling method and immunoreactivity and stability of (125)~Ⅰ-2F5 antibody against CD28; To evaluate the feasibility of specific tumor radioimmunoimaging (RII)using (125)~Ⅰ-2F5.Methods: 1. Iodogen method was used for (125)~Ⅰlabeling 2F5 monoclonal antibody. Labeling efficiency was calculated and the radiochemical purity was measured by using paper chromatography method. Immunoreactivity of (125)~Ⅰ-2F5 to CD28-T cell ( transfected with full-length human CD28 cDNA ) was determined. The stability of (125)~Ⅰ-2F5 in sodium chloride and human serum was analyed respectively, and the radiochemical purity was determined from 0h to 48h after adding to the medium. 2. After the normal nude mice were injected with (125)~Ⅰ-2F5 through tail veil, mice were sacrificed by cutting off carotid artery at different time points. The interested organs were excised, washed with saline, weighed, and counted on a gamma counter for calculating dose per gram of tissue (%ID/g). In the same way, organs and tumor tissue of BALB/c nude mice bearing a lymphoma(CD28-T) at 16h、24h、48h were excised for calculating %ID/g and tumor/non-tumor (T/NT) ratio. 3.Animal models including BALB/c nude mice bearing a lymphoma(CD28-T) and a non small cell lung cancer(A549) were established using 4~6 weeks female BALB/c nude mice. 11.1-14.8MBq/200μL (300-400μCi/200μL) (125)~Ⅰ-2F5 were injected intravenously and radioimmunoimages underwent using SPECT. In order to block thyroid, l%KI 200μL/d were administrated intragastricly three days before imaging. T/B (tumor/background) was analyzed by ROI (region of intest) technique.Results: 1.The Labeling efficiency of (125)~Ⅰ-2F5 was (68.12±6.19)%, and its radiochemical purity was (97.67±0.59)%. The radioactivity of (125)~Ⅰ-2F5 was 756.13 MBq/mg. The highest total binding efficiency of (125)~Ⅰ-2F5 with CD28-T cell was (37.31±0.85)%,and the specific binding efficiency was (34.44±0.93)%. The radiochemical purity of (125)~Ⅰ-2F5 was still above 90% after incubated both at 4℃and 37℃for 24h in control and 4h in sodium chloride.2. (125)~Ⅰ-2F5 in the normal nude mice and nude mice bearing tumor was eliminated mainly through the liver and kidney in vivo; After injection of (125)~Ⅰ-2F5, The distribution of radiotracer in tumor tissue and T/NT ratio increased gradually with the time, the highest value reached at 24h 3. After injection of (125)~Ⅰ-2F5, the tumor can be seen clearly in radioimmunoimages in BALB/c nude mice bearing a lymphoma(CD28-T). However, no high radioactive uptake was observed in tumor tissues of non small cell lung cancer (A549).Conclusion: 1. The high labeling efficiency and radiochemical purity were obtained.The stability of (125)~Ⅰ-2F5 is fine in vitro and (125)~Ⅰ-2F5 keeps its immune activity after Iodogen labeling.2.In nude mice bearing a lymphoma imaging, the tumor uptook (125)~Ⅰ-2F5 highly and can be seen clearly in RII. 3. Our study had laid basic experimental foundation for lymphoma radioimmunoimage and target therapy using different radioisotope iodine (123I、(125)~Ⅰ、131I) labeled mAb 2F5 .
|
Related Dissertations
- The Experimental Study of 131 Ⅰ Labeledanti-proGRP31-98 Single Chain Antibody,R392
- Methods for Clenbuterol Rapid Detection,S859.84
- Experimental Study on the Molecular Imaging and Therapy for VEGF Receptor-3 Binding Peptide Targeting Lymphangiogenesisa in Mouse with Ovarian Cancer,R737.31
- Preparation of Human Anti-HIF-1alpha Scfv of Lung Adenocarcinoma and Its Radioimmunoimaging in Tumor-bearing Nude Mice,R734.2
- Radioimmunoimaging of 131I Labelled Anti-alveolar Echinococcosis Polyclonal Antibodies in Rats with Echinococcus Multilocularis in Vivo,R532.32
- Expression and Purification of Protective Proteins of Mycobacterium Tuberculosis and Preparation of Monoclonal Antibodies Against Ag85B,R392
- Preparation and Preliminary Application of the Monoclonal Antibody Against 26-ku Periplasmic Protein of Brucella Species,R392
- Preparation of Monoclonal Antibody Against Lead and Establishment of ELISA Method,R392
- Expression and Purification of Heparanase in Prokaryotes and the Application of Its Antibody in Clinical Analysis,R446.6
- Monoclonal Antibody Preparation, Epitope Phenotyping and Clinical Application of Hepatitis B Surface Antigen (HBsAg),R392
- TNF-α monoclonal antibody treatment of rats with HPS mechanism of action,R575.2
- Preparation、Identification and Preliminary Application of Monoclonal Antibody Against Intercellular Adhesion Molecule-1,R392
- Lung function Isolation and identification of antigens associated with lung cancer study,R734.2
- Development of Monoclonal Antibodies Against Nucleocapsid Protein of PRRSV,S852.65
- Colloidal Gold Immuo-Chromatography Assay Method to Detect the Methamphetaminein Drug Addicts’ Urine,D919
- Preparation, Characterization and Immune Protective Role of A Monoclonal Antibody Against Human Respiratory Syncytial Virus,R392
- Human/Mouse CXCR3 Gene Transfected Cell Line Establishment and Mouse Anti-human CXCR3 Monoclonal Antibody Research and Its Function,R392
- Establishment of Human HVEM Transfected Cell Line and Preparation of Mouse Anti-human HVEM Monoclonal Antibody,R392
- Preparation and Biological Characterization of Mouse Anti-human 4-1BBL Monoclonal Antibodies,R392
- Preparation of LIGHT Transfected Cells and Monoclonal Antibody and Its Costimulatory Effect on T Cell in Vitro,R392
- Development of Monoclonal Antibodies Against Porcine Circovirus Type 2 (PCV2) and Immunohistochemistry Based on the McAbs and Its Potential Application in the PCV2 Antigen Detection from Lymph Nodes of Commercial Slaughter Pigs,S854.43
CLC: > Medicine, health > Basic Medical > Medical Immunology
© 2012 www.DissertationTopic.Net Mobile
|